Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-04447943 versus placebo in mild to moderate Alzheimer's disease on stable donepezil
2010-020427-43Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Alzheimer's disease (AD) comparing PF-04447943 + stable donepezil with Placebo + stable donepezil (2 arms). Primary endpoint: Alzheimer's Disease Assessment Scale Cognitive Subscale 70. Started Aug 2010; status: terminated.
02
Drugs
edelinontrine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2010-020427-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020427-43.